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The recognition of adverse effects due to environmentl endocrine disruptors in humans and wildlie has focused attention on the need for predictive tools to select the most likel estrogenic chemicals om a very large number of chemicals for subsequent screening and/or testing for potential environmental toxicity. A three-dimensional quantitative structure-activity relationship (QSAR) model using comparative molecular field analysis (CoMFA) was constructed based on relative binding affiity (RBA) data from an estrogen receptor (ER) bding assay using calf uterine cytosoL. The model demonted significant correation of the caculted steric and dectrostatic fields with RBA (1) . Estrogens elicit many cellular responses in target tissues and can exert both positive and negative effects on health and reproductive function. For example, estrogens are used beneficially for fertility control (oral contraception) (2) and for relief of menopausal symptoms (estrogen replacement therapy) (3) . The adverse developmental effects of diethylstilbestrol (DES) demonstrate human fetal sensitivity to estrogenic compounds (4) , while other xenoestrogens appear to disrupt endocrine function in wildlife and in laboratory animals (5, 6) . Recently, concern about the adverse effects of chemical compounds with estrogenic activity on humans and other species has grown rapidly (7) . Adverse effects on the development of reproductive capacity is the highest priority (8) . Another manifest concern is xenoestrogen involvement in some common cancers in women (9) . The emergence of the endocrine disruptor issue has resulted in new laws requiring evaluation of some chemicals found in foods or water for several types of hormonal activity (10, 11) .
Seventy thousand or more chemicals may ultimately need to be evaluated for estrogenic activity, and methods need to be developed to distinguish which of these should have highest priority for entry into the more expensive screening and testing procedures.
Because the chemical structures of xenoestrogens are highly diverse (12) , estrogenicity is not readily deduced from simple inspection of chemical structure. Therefore, risk assessments for estrogenic chemicals are basically dependent on in vivo assays (13) , such as uterine weight gain (14, 15) , which measures responses in estrogen sensitive tissues, and multigeneration studies, which assess reproductive performance. Supporting data may come from reporter gene assays (16) , cell proliferation assays (17) , or from in vitro studies of competition of estrogen binding to the estrogen receptor (ER) (18) . However, many in vivo assays are labor-intensive, time-consuming, and costly, which makes them impractical for routine screening and testing of a large number of chemicals.
Many estrogen responses are thought to be mediated via estrogen binding to the classical estrogen receptor (ER-a); this mechanism is the basis for the correlation between the ability of a chemical to compete for estradiol binding to ER and to induce estrogenic effects in vivo. Therefore, the determination of the pharmacophoric elements of ligands that bind to the ER is crucial to understanding the biological effects of estrogens (19) .
Over the past 30 years, a large volume of estrogen-related data has accumulated in the literature. These data cover molecular biology to medicine, developmental roles to adverse effects, evolutionary conservation to reproduction, and many other diverse and important disciplines. This huge estrogen database could be transformed into a knowledge base for regulatory and research purposes in part by understanding the basis of the relationship between chemical structure and estrogenic activity. Quantitative structure-activity relationship (QSAR) analysis correlates chemical structure and a specific biological activity, and the derived models are used to predict activities of untested chemicals. Ultimately, it is reasonable to expect that a number of such models may be necessary to cover a number ofpossible mechanisms of effects of chemicals on estrogenicity (e.g., ER-f, aromatase inhibition, etc.).
Since the pioneering work of Hansch and colleagues (20) in the 1960s, QSAR models have been applied extensively in various areas in chemistry and biology (21) . For environmental toxicology (22, QSAR is seen as a scientifically credible tool for predicting and classifying biological activities of chemicals when little or no actual data are available (23) . QSAR studies generally involve two steps: first, descriptors (physicochemical parameters) are generated which encode for chemical structural information; and second, a statistical regression method correlates changes in structure with changes in biological activity. The compounds in the training set (i.e., the data set selected to construct the QSAR model) should be diverse both in chemical structure and biological activity to ensure a statistically robust model. The QSAR method typically assumes that chemicals function by a common mechanism. The model is then validated by predicting the biological activity for a test set (i.e., a group of chemicals not included among the training-set compounds). Once validated, these QSAR models can be used to predict activities of untested chemicals.
Recent advances in computing technology have extended dassical QSAR to threedimensional QSAR (3D-QSAR) models that correlate the role of molecular shape with some endpoints which are usually biological in nature. A widely used approach for generating descriptors based on the three-dimensional structural information of molecules is comparative molecular field analysis (CoMFA) (24) , which is recognized as a versatile and powerful tool in rational drug design (25) and related applications (26) . CoMFA (27) (28) (29) (30) (31) and for related steroids and their receptors (32) (33) (34) (37) , and glass transition temperatures (38) , among other physical properties of compounds. We investigated the utility of the CODESSA-generated descriptors for QSAR studies and as a complementary tool to understand ER binding of estrogens.
Materials and Methods
Data sets for analysis. von Angerer and coworkers (39-41) have sought to develop potent antiestrogens based on nonsteroidal structures. Among their prototype structures are the 2-phenylindoles, for which extensive structure-activity relationship (SAR) studies have been done (39) . We selected 53 estrogenic compounds from von Angerer's database as the training set to determine the steric and electrostatic requirements for recognition at the ER binding site. In most previous CoMFA studies of ER binding (27) (28) (29) (30) (31) , the data sets either consisted of congeneric compounds or were not of good quality, which limited the general applicability of these models to serve as screens for potential estrogens. In the present study, several naturally occurring and synthetic estrogens ( Fig. 1) were added to the 2-phenylindoles to increase the structural diversity and to span a larger range of RBA values within the training set. The chemical structures of the 53 compounds, organized by chemical class, are shown in Figure 1 and Tables 1  and 2 . The RBAs were calculated from a calf uterine estrogen receptor (calf ER) competitive binding assay with [3H] 171-estradiol (E2). The RBA is the ratio of the molar concentrations of E2 and the competing chemical required to decrease the receptor-bound radioactivity by 50%, multiplied by 100; thus, E2 has an RBA of 100.
The test set comprised the 16 estrogenic compounds shown in Figure 2 . Among these, the RBA values for 14 steroidal compounds were measured in a competitive ER binding assay using human MCF-7 cell cytosol (42) . The binding affinities of 4 of the 16 compounds, estrone, estriol, moxestrol, and zindoxifen, were measured in the same calf ER binding assay used in the training set. Within the test set, only two estrogens, estrone and estriol, were measured in both binding assays.
Molecular modeling. The structures of the 2-phenylindole analogs were constructed from the Sybyl 6.1 fragment database (Tripos Inc., St. Louis, MO ). The remaining compounds were built based on the crystal structures of estradiol and DES, which were obtained from the Cambridge Structural Database (CSD; University Chemical Laboratory, Cambridge, U.K.). Because a single conformation is assumed in CoMFA studies for a ligand binding to a receptor, a binding conformation of the molecules being studied must be postulated (29) . In the absence of experimental evidence on the binding conformation of estrogens, we used the structure based on the global minimum-energy conformation, which is standard practice in CoMFA studies (24) . The global minimum-energy conformation was computed in three steps: 1) the geometry of each molecule was optimized to its nearest local minimum-energy conformation to an energy gradient of 0.001 kcal/mol A using the standard Tripos molecular mechanics force field with a distancedependent (1/r) dielectric function; 2) these energy-minimized structures were then subjected to conformational analysis using a systematic search over all rotatable bonds at 100 increments; and finally, 3) the molecules were reminimized by setting to their identified minimum-energy torsion angles. All atomic partial charges were computed using the Gasteiger-Marsili method (43 Figure 1 were aligned in a similar manner. For the triphenylethylenes, the equivalent points are the centroids of the A-and C-rings, and the C1 atom of the Bring (or of the ethyl group in hexestrol). This fitting procedure was followed by a field fit optimization to the template molecule. The field fit adjusts the geometry of the molecules to maximize the similarity of the steric and electrostatic fields between the template and training molecules. Because this procedure sometimes causes structural distortions, the molecules were subsequently reoptimized to relax the fitted molecules to the nearest local minimumenergy structure.
After alignment, the molecules were placed in a three-dimensional cubic lattice with 2 A spacing. The steric and electrostatic fields were calculated at each mesh point using an sp3 carbon probe with +1.0 charge based on the van der Waals (LJ potential) interactions inner green region indicating that the presence of steric bulk in this region, such as the ethyl substituents in compounds 7a or 1 la, will enhance RBA. Beyond the green region is a yellow region where additional steric bulk, such as in compounds 9a or 24a, will diminish RBA.
The red and blue polyhedra describe regions of space where an increase in negative charge is associated with increased and decreased RBA, respectively. The blue con- tour surrounding the 3'-position of the phenyl moiety of the 2-phenylindoles suggests that the presence of the OH substituent at this position decreases RBA and gives a rational explanation for the lower RBA of compounds 29a to 36a compared with the corresponding analogs where substitution is at the 4'-position (compounds 7a, lOa-12a, 18a, and 20a-22a). The CoMFA model so derived was used to predict the activity of the test compounds shown in Figure 2 . Since four compounds (estrone, estriol, moxestrol, and zindoxifen) were assayed identically to those in the training set, they provide an additional means to assess the predictive significance of the model. There is very good agreement between the actual and predicted RBA values for these four test compounds with small residuals similar to that obtained for the training set results ( Fig. 3 and Table 4 ). The model predicted estrone, estriol, and moxestrol to have moderate binding affinities, while zindoxifen is predicted to have relatively weak receptor binding.
As seen in CODESSA-PLS. The CODESSA-PLS model for the same set of 53 compounds required three principal components to explain the variance in biological activity. As in CoMFA-PLS, the optimum number of components was determined using the LOO cross-validation procedure. The key statistical parameters for this model are q 2 = 0.54, r2= 0.68, SE = 0.55, F= 30.3, andp<0.001. The CODESSA results for the calculated log RBAs are likewise given in Table 3 . A plot of the experimental versus calculated RBA values for the training set compounds is shown in Figure 5 . It can be seen that there is an obvious outlier in compound 28a. Removing this compound from the training set improved the conventional r2 (0.80). Table   1 shows that compound 28a is the only one la  2a  3a  4a  5a  6a  7a  8a  9a  10a  Ila  12a  13a  14a  15a  16a  17a  18a  19a  20a  21a  22a  23a  24a  25a  26a  27a  28a  29a  30a  31a  32a  33a  34a  35a  36a  ZK 119,010  lb  2b  3b  4b  5b  6b  7b  8b  9b  10b   E2   ICI 164,384  ICI 182,780  TAM  OH- The absence of color represents regions that were unexamined by the current data set. Experimental leg RBA in which the OH-substituent is at the 7-position. It appears that the difference in the position of this functional group, while possibly encoded in the descriptors, cannot be easily distinguished by the CODESSA methodology. Indeed, for compounds 1 la, 21a, and 28a, for example, where only the position of substituent X is changing, i.e., positions 6, 5, and 7, respectively, the calculated log RBA values are close to each other (calculated log RBA = 0.67, 0.65, and 0.58, respectively). On the contrary, the experimental RBA values for these compounds significantly decrease as the OH-substituent is moved from the 6-, 5-, and 7-positions (experimental log RBA = 1.52, 0.98, and -1.70, respectively).
The CODESSA-PLS methodology gives the PLS X-loadings, which were examined in order to delineate the relative contribution of each molecular descriptor to the regression model. The molecular descriptors with highly positive or highly negative PLS loadings (regarded as the most important) were associated with the quantum chemical and electrostatic descriptors that encode the features responsible for polar interactions between molecules. This is consistent with the CoMFA results in which the electrostatic field had a greater contribution to estrogenic activity than did steric fields. (49) .
Regardless of the criteria applied to RBA values to define a chemical as estrogenic, it should be appreciated that perfect predictivity of RBAs is not required at the initial screening step. Rather, the incidence of false negatives (actual ER binding chemicals that appear negative in the screen) is of greatest concern, as these may not be further tested in a timely way. False positives (classifying a chemical as an ER ligand if the chemical actually does not bind) are of much less concern; they would be eliminated at higher tiers in the test battery. We are designing additional approaches that can be used in conjunction with the QSAR models such as described here to help in determining criteria for selecting chemicals for more extensive testing.
Our analysis indicates that the COMFA model is superior in precision to the CODESSA model for the present application. It appears that the CODESSA descriptors as implemented in the PLS procedure were unable to capture those factors that influence the variations in RBA and, therefore, limit the correlation between the RBAs and certain structural differences in the training set. It may also be possible that a nonlinear relationship exists between the descriptors and RBAs, which can be addressed by other nonlinear regression methods such as artificial neural networks.
Compared with CODESSA-PLS, CoMFA appears better able to explain estrogen receptor binding variation in terms of the steric and electrostatic requirements. However, when used in appropriate cases, CODESSA-PLS is certainly less prone to arbitrariness (e.g., alignment) and is procedurally less difficult to implement. Importantly, the level of precision with CoMFA seems more than adequate for the intended purpose, while the range of predictability of RBAs at 10,000-fold is quite large. Further development of this model is currently underway.
In summary, we have shown the feasibility of using computational methods to predict the RBAs of chemicals untested for estrogenic activity. Such predictions should allow selection of the highest priority chemicals for testing, resulting in information on estrogenic activity to be obtained more quickly than if no priority criteria existed.
